This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Cognex, UnitedHealth: Analysts' New Ratings

Stocks in this article: AMTD BWC CGNX UNH TCO PPL OLN

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

TD Ameritrade (AMTD - Get Report) rated new Neutral at UBS. $23 price target. Company is a market leader, but appears fully valued at current levels.

Babcock & Wilcox (BWC - Get Report) downgraded at Keybanc from Buy to Hold, Keybanc said. Valuation call.

Babcock & Wilcox (BWC - Get Report) numbers raised at Goldman. Shares of BWC now seen reaching $34, according to Goldman Sachs. Estimates also increased, given higher emissions control demand. Neutral rating.

Cognex (CGNX - Get Report) upgraded at Piper from Neutral to Overweight, Piper Jaffray said. $34 price target. Stock has pulled back 24% since earnings.

Coventry Health (CVH) upgraded at Stifel to Buy. Estimates also raised, as the company is seeing lower medical costs. $38 price target.

Discovery Communications (DISCA) initiated at Credit Suisse with a $45 price target and Neutral rating. Pure play cable programmer with faster than average top line growth, Credit Suisse said.

General Growth Properties (GGP) upgraded at Credit Suisse to Outperform from Neutral. Best positioned for the CMBS recovery, Credit Suisse said. Maintain $18 price target.

Nalco (NLC) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. Valuation call, based on a $30 price target. Stock is down 20% this year, largely because of the Berkshire overhang.

Olin (OLN - Get Report) upgraded at UBS from Sell to Neutral, UBS said. $19 price target. JV acquisition is a good strategy.

PPL (PPL - Get Report) estimates upped at Morgan Stanley through 2013, Morgan Stanley said. Overweight rating and $28 price target.

PPL (PPL - Get Report) upgraded at FBR from Market Perform to Outperform, FBR Capital Markets said. $29 price target. Stock has pulled back, even though the recent acquisition should add to earnings.

Taubman Centers (TCO - Get Report) downgraded at Credit Suisse to Neutral from Outperform. Valuation call, Credit Suisse said. Maintain $39 price target.

UnitedHealth (UNH - Get Report) upgraded at Stifel to Buy. $56 price target. Estimates also boosted, because of lower expected medical costs.

United Rentals (URI) rated new Buy at Goldman. Company is in the early stages of a pricing recovery and can deliver above-average earnings growth.

Wellpoint (WLP) upgraded at Stifel to Buy. $85 price target. Business fundamentals are improving.

Watts Water (WTS) upgraded at BB&T to Buy, BB&T Capital said. $47 price target. End-market demand will eventually come around and drive above-average growth.

This article was written by a staff member of TheStreet.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs